RAPT Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. RAPT

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/9/2024

Shares

14,743

Value ($000)

132

Weight

0.0%

2022 Q3 - 2024 Q1 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/9/2024	132	0.0%	14,743	3/31/2024
2022 Q3	11/10/2022	226	0.0%	9,413	9/30/2022